These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 2443088)
1. Angiostatic steroids. Method of discovery and mechanism of action. Folkman J; Ingber DE Ann Surg; 1987 Sep; 206(3):374-83. PubMed ID: 2443088 [TBL] [Abstract][Full Text] [Related]
2. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Crum R; Szabo S; Folkman J Science; 1985 Dec; 230(4732):1375-8. PubMed ID: 2416056 [TBL] [Abstract][Full Text] [Related]
3. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Ingber DE; Madri JA; Folkman J Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis through modulation of collagen metabolism. Ingber D; Folkman J Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830 [TBL] [Abstract][Full Text] [Related]
5. Control of angiogenesis with synthetic heparin substitutes. Folkman J; Weisz PB; Joullié MM; Li WW; Ewing WR Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase. Chen NT; Corey EJ; Folkman J Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by suramin. Gagliardi A; Hadd H; Collins DC Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by aurintricarboxylic acid. Gagliardi AR; Collins DC Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120 [TBL] [Abstract][Full Text] [Related]
9. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. McNatt LG; Weimer L; Yanni J; Clark AF J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Blei F; Wilson EL; Mignatti P; Rifkin DB J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis. Sakamoto N; Tanaka NG Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551 [TBL] [Abstract][Full Text] [Related]
13. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270 [TBL] [Abstract][Full Text] [Related]
14. Toward a new understanding of vascular proliferative disease in children. Folkman J Pediatrics; 1984 Nov; 74(5):850-6. PubMed ID: 6208529 [TBL] [Abstract][Full Text] [Related]
15. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Folkman J Cancer Res; 1986 Feb; 46(2):467-73. PubMed ID: 2416426 [No Abstract] [Full Text] [Related]
16. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Hori Y; Hu DE; Yasui K; Smither RL; Gresham GA; Fan TP Br J Pharmacol; 1996 Aug; 118(7):1584-91. PubMed ID: 8842418 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Folkman J; Langer R; Linhardt RJ; Haudenschild C; Taylor S Science; 1983 Aug; 221(4612):719-25. PubMed ID: 6192498 [TBL] [Abstract][Full Text] [Related]
19. [Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"]. Szekanecz Z; Bordán E; Szabó Z; Szegedi G Orv Hetil; 1998 Feb; 139(5):227-34. PubMed ID: 9489376 [TBL] [Abstract][Full Text] [Related]
20. The rationale and future potential of angiogenesis inhibitors in neoplasia. Gasparini G Drugs; 1999 Jul; 58(1):17-38. PubMed ID: 10439927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]